PDSB

PDS Biotechnology Corporation

Price

$0.21

return (12m)

-82.84%

p/e

-0.36

p/bv

-3.39

DIVIDEND YIELD

0.00%

PDSB price

PDS Biotechnology

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment PDSB

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-68.76%

3 months

-80.30%

1 year

-82.84%

2 years

-93.11%

5 years

-98.57%

10 years

-99.88%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals PDSB

Valuation

P/E

-0.36

Sector -4.26

Industry -4.26

P/BV

-3.39

Sector 2.11

Industry 2.11

P/Revenue (PSR)

Sector 2.08

Industry 2.08

EV/EBITDA

Sector -546.19

Industry -546.19

EV/EBIT

Sector -37.31

Industry -37.31

P/EBITDA

Sector -50.76

Industry -50.76

P/EBIT

Sector -39.62

Industry -39.62

P/Total Assets

1.38

Sector 1.25

Industry 1.25

P/Net Current Assets

-2.27

Sector -5.47

Industry -5.47

P/Working Capital

-2.27

Sector -1.10

Industry -1.10

EPS

-0.60

Sector -1.94

Industry -1.94

BVPS

-0.06

Sector 1.89

Industry 1.89

Efficiency

Gross Margin

0.00%

Sector 38.90%

Industry 38.90%

EBITDA Margin

Sector -13,872.56%

Industry -13,872.56%

EBIT Margin

Sector -4,253,834.43%

Industry -4,253,834.43%

Operating Margin

0.00%

Sector -36.74%

Industry -36.74%

Net Profit Margins

0.00%

Sector -37.51%

Industry -37.51%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

940.50%

Sector -61.50%

Industry -61.50%

ROA

-382.18%

Sector -63.85%

Industry -63.85%

ROIC

0.00%

Sector -498.30%

Industry -498.30%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

0.57

Sector 2.89

Industry 2.89

Net Debt / EBITDA

Sector -39,048,222.71

Industry -39,048,222.71

Net Debt / EBIT

Sector -10.24

Industry -10.24

Net Debt / Equity

0.00

Sector -0.60

Industry -0.60

Gross Debt / Equity

0.00

Sector -0.83

Industry -0.83

Equity/Assets

-0.41

Sector 0.43

Industry 0.43

Liabilities/Assets

1.41

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

14.75%

Sector -

Industry -

Fundamentals PDSB

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
PDSB PDS Biotechnology Corporation	$0.21	-83.38%	0.00%	-0.36	-3.39	940.50%	0.00%
JNJ Johnson & Johnson	$266.50	55.29%	1.93%	31.09	7.70	24.76%	21.48%
PFE Pfizer Inc.	$27.87	21.03%	6.26%	35.86	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$256.91	27.42%	2.58%	74.16	-78.93	-106.44%	9.81%
NVO Novo Nordisk A/S	$45.62	-14.65%	3.95%	11.47	6.09	53.11%	35.32%
MRK Merck & Co. Inc.	$147.77	82.61%	2.24%	116.78	8.81	7.55%	4.76%
AZN AstraZeneca PLC	$161.98	3.71%	1.93%	24.59	5.10	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$66.29	45.78%	3.73%	14.81	6.16	41.55%	18.85%
ZTS Zoetis Inc.	$76.84	-49.43%	2.67%	12.20	10.25	84.02%	27.77%
REGN Regeneron Pharmaceuticals Inc.	$792.43	37.47%	0.44%	19.71	2.69	13.65%	27.86%
AMGN Amgen Inc.	$432.42	55.55%	2.22%	27.25	20.39	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$105.00	43.48%	0.00%	30.73	88.55	288.14%	24.86%
MCK McKesson Corporation	$897.16	31.93%	0.38%	19.60	-26.88	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$542.40	39.41%	0.00%	31.57	6.87	21.76%	35.00%
CAH Cardinal Health Inc.	$235.19	59.60%	0.88%	35.20	-20.39	-57.93%	0.62%
HRMY Harmony Biosciences Holdings Inc.	$39.29	3.26%	0.00%	12.32	2.23	18.14%	18.89%
BIIB Biogen Inc.	$217.24	59.31%	0.00%	38.68	1.71	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

PDSB Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT PDS Biotechnology

PDS Biotechnology Corporation

Average Investor10 user rating

4.0 (0 people)

United States

17 years

Founded: 2009

2015

Time since IPO - 11 years

15

Employees

PDS Biotechnology Corporation (United States) is listed on the Nasdaq and has a market capitalization of $12.14 million, with shareholders equity totaling $-3.58 million.

The company employs approximately 15 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, PDS Biotechnology Corporation reported $- in revenue, generating net income of $-33.67 million.

Key financial metrics include a P/E ratio of -0.36, a price-to-book (P/B) ratio of -3.39, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker PDSB.

Market cap

$12.14 million

Net worth

$-3.58 million

$-3,580,000.00

Assets

$8.81 million

$8,810,000.00

Total Shares Outstanding

56.00 million

56,000,000

Average Daily Trading Volume

$1.36 million

$1,361,111.78

Sector

Health Care

Industry

Biotechnology

PDSB

PDSB revenue and profits

Financial Results PDSB

DRAG THE FRAME TO SEE MORE DATA

PDSB cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$897.16 31,33% (12M)

P/E

19.60

0.38%

ROE

-137.16%

P/BV

-26.88

CAH - Cardinal Health

$235.19 60,10% (12M)

P/E

35.20

0.88%

ROE

-57.93%

P/BV

-20.39

JNJ - Johnson & Johnson

$266.50 54,96% (12M)

P/E

31.09

1.93%

ROE

24.76%

P/BV

7.70

ABBV - AbbVie

$256.91 26,00% (12M)

P/E

74.16

2.58%

ROE

-106.44%

P/BV

-78.93

MRK - Merck & Co.

$147.77 82,50% (12M)

P/E

116.78

2.24%

ROE

7.55%

P/BV

8.81

AZN - AstraZeneca

$161.98 3,46% (12M)

P/E

24.59

1.93%

ROE

20.74%

P/BV

5.10

PFE - Pfizer

$27.87 22,54% (12M)

P/E

35.86

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$897.16 31,33% (12 M)

P/L

19.60

0.38%

ROE

-137.16%

P/VP

-26.88

CAH - Cardinal Health

$235.19 60,10% (12 M)

P/L

35.20

0.88%

ROE

-57.93%

P/VP

-20.39

JNJ - Johnson & Johnson

$266.50 54,96% (12 M)

P/L

31.09

1.93%

ROE

24.76%

P/VP

7.70

ABBV - AbbVie

$256.91 26,00% (12 M)

P/L

74.16

2.58%

ROE

-106.44%

P/VP

-78.93

MRK - Merck & Co.

$147.77 82,50% (12 M)

P/L

116.78

2.24%

ROE

7.55%

P/VP

8.81

AZN - AstraZeneca

$161.98 3,46% (12 M)

P/L

24.59

1.93%

ROE

20.74%

P/VP

5.10

PFE - Pfizer

$27.87 22,54% (12 M)

P/L

35.86

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of PDS Biotechnology (PDSB) today?

A cotação de PDS Biotechnology (PDSB) hoje está em US$ 0.21, com uma variação de -82.84% em relação ao último ano. A cotação de PDS Biotechnology (PDSB) iniciou o ano negociando na casa dos US$ 0.77 e hoje está em US$ 0.21. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de PDS Biotechnology (PDSB) e dados de ações do Ibovespa e mercados internacionais.

Quando PDS Biotechnology (PDSB) paga dividendos?

PDS Biotechnology (PDSB) não distribuiu dividendos no último ano.

Is PDS Biotechnology (PDSB) a good investment?

Atualmente, PDS Biotechnology (PDSB) está cotada a US$ 0.21, com um P/L de -0.36, representando um desvio de -339% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de -82.84 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de -82.84%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy PDS Biotechnology (PDSB) stock?

Investir em ações de PDS Biotechnology (PDSB) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of PDS Biotechnology (PDSB) yield today?

A rentabilidade de PDS Biotechnology (PDSB) foi de -68.76% no último mês, -82.84% no último ano e -98.57% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de PDS Biotechnology (PDSB) hoje, o investimento total seria de US$ 21.28, com base na cotação atual de US$ 0.21.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 3.65
Em 5 anos: US$ 0.30
Em 10 anos: US$ 0.03

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

PDSB

PDS Biotechnology Corporation

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment PDSB

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING PDSB WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT PDS Biotechnology

PDS Biotechnology Corporation

United States

17 years

2015

15

PROFIT X PRICE PDSB

Financial Results PDSB

PDSB cash flow

Asset, Revenue and Profit Growth - PDSB

PDSB balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions